GPC3 and hepatocellular carcinoma: In mice experiments (including immunodeficient mice), inhibition of PD-1 expression in GPC3-CAR-T cells enhances their killing effect on tumor cells and dramatically reduces tumor load while protecting themselves from exhaustion in combating native PD-L1-expressing HCC [5].